A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects

Clinical trial NCT00363142 · COMPLETED

Trial details

NCT number: NCT00363142
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

HIV Infection Infection, Human Immunodeficiency Virus

Start date: 2006-05-01
Primary completion: 2008-06-01
Enrollment: 211

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.